Evidence map›Paper›PMID 22466613›Full record

ArticleNature genetics2012

Multiple apical plasma membrane constituents are associated with susceptibility to meconium ileus in individuals with cystic fibrosis.

Lei Sun, Johanna M Rommens, Harriet Corvol, Weili Li, Xin Li, Theodore A Chiang, Fan Lin, Ruslan Dorfman, Pierre-François Busson, Rashmi V Parekh and 19 more

2 registry-linked trialsOpen access · greenAbstract read
In one paragraph

Article in Nature genetics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 113 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
113citing papers in PubMed, 6 pooled it
12.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00037765 active not recruitingnot on this map

Gene Modifiers of Cystic Fibrosis Lung Disease

TypeobservationalSponsorUniversity of North Carolina, Chapel HillRan2001 to 2027Enrolled600ConditionsCystic Fibrosis, Lung Diseases
NCT00804583 active not recruitingnot on this map

Genetic Modifiers of CF Liver Disease

TypeobservationalSponsorUniversity of North Carolina, Chapel HillRan2004 to 2027Enrolled154ConditionsCystic Fibrosis, Liver Disease
3 · Its place in the literature

Who cites it

113 citing papers in PubMed, 6 syntheses or guidelines pooled it, 208 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Impact of Genetics on Endocrine Manifestations of Cystic Fibrosis.Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2026
    Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. SLC26 Anion Transporters.Handbook of experimental pharmacology · 2024
    Review
  18. Article
  19. Review
  20. Article

53 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 7 institutions in 3 countries.

Lei SunBiostatistics Division, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Johanna M Rommens
Harriet Corvol
Weili Li
Xin Li
Theodore A Chiang
Fan Lin
Ruslan Dorfman
Pierre-François Busson
Rashmi V Parekh
Diana Zelenika
Scott M Blackman
Mary Corey
Vishal K Doshi
Lindsay Henderson
Kathleen M Naughton
Wanda K O'Neal
Rhonda G Pace
Jaclyn R Stonebraker
Sally D Wood
Fred A Wright
Julian Zielenski
Annick Clement
Mitchell L Drumm
Pierre-Yves Boëlle
Garry R Cutting
Michael R Knowles
Peter R Durie
Lisa J Strug
Hospital for Sick Children · CAUniversity of North Carolina at Chapel Hill · USJohns Hopkins University · USUniversity of Toronto · CAInserm · FRCase Western Reserve University · USCommissariat à l'Énergie Atomique et aux Énergies Alternatives · FR

Funding

Translational Research in Cystic FibrosisP30DK027651 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI DRUMM, MITCHELL L · 1986 to 2014
$15.6M
Gene Modifiers in CF Lung DiseaseR01HL068890 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KNOWLES, MICHAEL R · 2001 to 2014
$9.5M
Genetic Modifiers of Cystic Fibrosis: Sibling StudyR01HL068927 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI CUTTING, GARRY R · 2001 to 2011
$8.9M
Genetic Modifiers of CF Liver DiseaseR01DK066368 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KNOWLES, MICHAEL R · 2004 to 2008
$3.2M
Molecular Phenotypes for Cystic Fibrosis Lung DiseaseR01HL095396 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KNOWLES, MICHAEL R, WRIGHT, FRED A. · 2008 to 2011
$2.9M
Genetic modifiers of diabetes in cystic fibrosisK23DK083551 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI BLACKMAN, SCOTT M · 2009 to 2013
$877k
Development of "Evidential" Methodology for the Analysis of Genetic DataR03HG004314 · NHGRI · HOSPITAL FOR SICK CHLDRN (TORONTO) · PI STRUG, LISA JOANNA · 2008 to 2009
$124k
CIHR MOP 258916CIHR MOP 84287NHGRI NIH HHS HG-0004314NHGRI NIH HHS R03 HG004314NHLBI NIH HHS R01 HL068890NHLBI NIH HHS R01 HL068927NHLBI NIH HHS R01 HL095396NHLBI NIH HHS R01 HL68927NIDDK NIH HHS K23 DK083551NIDDK NIH HHS P30 DK027651NIDDK NIH HHS R01 DK066368
6 · The paper itself

Abstract

Variants associated with meconium ileus in cystic fibrosis were identified in 3,763 affected individuals by genome-wide association study (GWAS). Five SNPs at two loci near SLC6A14 at Xq23-24 (minimum P = 1.28 × 10(-12) at rs3788766) and SLC26A9 at 1q32.1 (minimum P = 9.88 × 10(-9) at rs4077468) accounted for ~5% of phenotypic variability and were replicated in an independent sample of affected individuals (n = 2,372; P = 0.001 and 0.0001, respectively). By incorporating the knowledge that disease-causing mutations in CFTR alter electrolyte and fluid flux across surface epithelium into a hypothesis-driven GWAS (GWAS-HD), we identified associations with the same SNPs in SLC6A14 and SLC26A9 and established evidence for the involvement of SNPs in a third solute carrier gene, SLC9A3. In addition, GWAS-HD provided evidence of association between meconium ileus and multiple genes encoding constituents of the apical plasma membrane where CFTR resides (P = 0.0002; testing of 155 apical membrane genes jointly and in replication, P = 0.022). These findings suggest that modulating activities of apical membrane constituents could complement current therapeutic paradigms for cystic fibrosis.

Indexed as

Genetic Predisposition to DiseaseMeconiumAmino Acid Transport SystemsAmino Acid Transport Systems, NeutralAntiportersCell MembraneCystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorGenome-Wide Association StudyGenotypeHumansIleusIntestinal ObstructionPolymorphism, Single NucleotideSodium-Hydrogen Exchanger 3Sodium-Hydrogen ExchangersAmino Acid Transport SystemsAmino Acid Transport Systems, NeutralAntiportersCFTR protein, humanCystic Fibrosis Transmembrane Conductance RegulatorSLC26A9 protein, humanSLC6A14 protein, humanSLC9A3 protein, humanSodium-Hydrogen Exchanger 3Sodium-Hydrogen ExchangersSulfate Transporters

Identifiers

PMID22466613
PMCPMC3371103
OpenAlexW2036275580

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.